erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Tuberculosis D014376 20 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Otitis Media D010033 12 associated lipids
Adenocarcinoma D000230 166 associated lipids
Bacterial Infections D001424 21 associated lipids
Otitis Externa D010032 8 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Stomach Diseases D013272 7 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Alveolitis, Extrinsic Allergic D000542 6 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
LOWBURY EJ and HURST L The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin, and spiramycin. 1959 J. Clin. Pathol. pmid:13641436
DELNON I and BERGER M [Comparative bacteriological and animal experimental studies on ristocetin ("spontin") and ilotycin ("erythrocin")]. 1959 Praxis pmid:13815708
GHOSH S and GHOSH R Donovanosis treated with erythromycin parenterally. Report of first case. 1959 Br J Vener Dis pmid:13827776
VIALLIER J et al. [Comparative study of the blood level of active erythromycin obtained in the human organism by administration of base or of propionate]. 1959 C. R. Seances Soc. Biol. Fil. pmid:13842057
TREFOUEL J et al. [Not Available]. 1959 Therapie pmid:13647435
MOYES EN and KALINOWSKI SZ Prophylactic chemotherapy in chronic bronchitis. 1959 Tubercle pmid:13647663
STAHLMAN MT and DENNY FW The prophylaxis of streptococcal infections in patients with rheumatic fever; a comparison between sulfadiazine and erythromycin. 1959 AMA J Dis Child pmid:13660627
HIRSCH HA and FINLAND M Effect of food on the absorption of erythromycin propionate, erythromycin stearate and triacetyloleandomycin. 1959 Am. J. Med. Sci. pmid:13661157
PERRY DM et al. Triacetyloleandomycin and erythromycin: a comparison of in vitro activity and of blood levels obtained after oral administration. 1959 Antibiotic Med Clin Ther (New York) pmid:13661850
TIDWELL RA and LEWIS D Erythromycin prophylaxis: a four year study. 1959 Antibiotic Med Clin Ther (New York) pmid:13661855
BROCK TD and BROCK ML Similarity in mode of action of chloramphenicol and erythromycin. 1959 Biochim. Biophys. Acta pmid:13651221
SHIMOHIRA M [Mode of action of the antagonism and additive effects caused by the combination of erythromycin and other antibacterial substances. II. Effect of the combination of erythromycin and penicillin on M. pyogenes having the capacity of producing penicillinase]. 1959 Jpn. J. Microbiol. pmid:14446017
DUPERRAT and PRINGUET [Dramatic Herxheimer phenomenon in the course of treatment of severe furunculosis by indicated antibiotics]. 1959 Jan 9-16 Bull Mem Soc Med Hop Paris pmid:13629325
ISKRZHITSKAIA AI and BLIUMENTAL' KV [Use of antibiotics of the tetracycline series and of erythromycin in experimental]. 1959 Jul-Aug Antibiotiki pmid:13848469
TEBIAKINA AE and SEMENOV SM [Determination of biological activity of erythromycin in all stages of its production]. 1959 Jul-Aug Antibiotiki pmid:13837248
LIMSON BM and ARAGON PR Current status of erythromycin. Laboratory and clinical studies on propionyl erythromycin. 1959 Jul-Sep Acta Med Philipp pmid:13762201
ALBORNOZ PLATA A [Erythromycin-carbarsone in the treatment of amebiasis]. 1959 Oct-Dec Rev Fac Med Univ Nac Colomb pmid:13792418
CALESNICK B Effectiveness of oral erythromycin propionate in commonly occurring infections. 1959-1960 Antibiot Annu pmid:13806941
MARMELL M et al. Clinical trial of erythromycin propionate for acute anterior gonococcal urethritis. 1959-1960 Antibiot Annu pmid:14421354
REICHELDERFER TE et al. Clinical studies of propionyl erythromycin lauryl sulfate in children. 1959-1960 Antibiot Annu pmid:14437052
SALITSKY S et al. Erythromycin propionate: a clinical and laboratory study. 1959-1960 Antibiot Annu pmid:14441020
PRASAD AS Severe urticaria following erythromycin therapy. 1960 Acta Med Iran pmid:14488491
HAMILTON WJ and MARTIN RJ Significance of zones of inhibition produced by penicillin and erythromycin on the genus Proteus. 1960 J Med Lab Technol pmid:13711025
HENNEQUET A and MELEKIAN B [100 patients treated with erythromycin propionate]. 1960 Rev Prat pmid:13713358
HERRELL WE et al. Erythrocillin: a new approach to the problem of antibiotic-resistant staphylococci. 1960 Antibiotic Med Clin Ther (New York) pmid:13713711
BIEGELEISEN JZ and MOODY MD Sensitivity in vitro of eighteen strains of Pasteurelia tularensis to erythromycin. 1960 J. Bacteriol. pmid:13800534
BLOUGH HA et al. Serum levels and clinical results with erythromycin propionate. 1960 Am. J. Med. Sci. pmid:13801645
BRUNO F [Erythromycin and cortisone-like agents in the treatment of diphtheria]. 1960 Clin Ter pmid:13805370
CHRISTIAN JR Comparison of ocular reactions with the use of silver nitrate and erythromycin ointment in ophthalmia neonatorum prophylaxis. 1960 J. Pediatr. pmid:13810126
CLAPPER WE et al. An evaluation of erythromycin stearate and propionyl erythromycin in normal and hospitalized subjects. 1960 Antibiotic Med Clin Ther (New York) pmid:13810414
CORCORAN JW et al. Actinomycete antibiotics. I. The biological incorporation of propionate into the macrocyclic lactone of erythromycin. 1960 J. Biol. Chem. pmid:13811922
CRONK GA and NAUMANN DE The treatment of infections with erythromycin propionate. 1960 Antibiotic Med Clin Ther (New York) pmid:13812968
DELTA BG and SCOTT RB Erythromycin propionate ointment in the treatment of cutaneous bacterial infections in children. 1960 Antibiotic Med Clin Ther (New York) pmid:13815757
LIMSON BM and ARAGON PR Clinical and in vitro efficacy of propionyl erythromycin ester. 1960 Antibiotic Med Clin Ther (New York) pmid:13762200
GRIFFITH RS Comparison of antibacterial activity in the sera of subjects ingesting propionyl erythromycin lauryl sulfate and erythromycin ethyl carbonate. 1960 Antibiotic Med Clin Ther (New York) pmid:13851768
MANIAR AC et al. A comparison of the in vitro and in vivo activity of erythromycin and spiramycin. 1960 Antibiot Chemother (Northfield) pmid:13766168
MARGGRAF W and GREGL A [Experiences with erycin in surgical patients]. 1960 Munch Med Wochenschr pmid:13766673
VEIS RA and EDEL'SHTEIN SI [Erythromycin (erythrocin, ilotycin)]. 1960 Ter. Arkh. pmid:13780602
DOBRZANSKI WT and PULAWSKA E [Studies on the role of mutation in erythromycin resistance in strains of staphylococci belonging to various phage groups]. 1960 Med Dosw Mikrobiol pmid:13723289
DOONER H et al. [Treatment of staphylococcal infections with erythromycin propionate]. 1960 Rev Med Chil pmid:13723831
KONIAR H and SZYMANSKA-MALOTTKE R [Sensitivity to erythromycin of Staphylococcus aureus from various origins]. 1960 Med Dosw Mikrobiol pmid:14410850
LONDRILLO A [Research on the action of erythromycin on guinea pigs inoculated with Bacillus anthracis]. 1960 Boll. Soc. Ital. Biol. Sper. pmid:14418101
MARSON P and AZERAD E [Clinical trials of an ester of erythromycin]. 1960 Gaz Med Fr pmid:14421574
PING RS and MORRIS EE Ilosone, the propionyl ester of erythromycin. 1960 Oral Surg. Oral Med. Oral Pathol. pmid:14433069
QUINN EL et al. Comparative studies of erythromycin propionate, erythromycin stearate, and triacetyloleandomycin. 1960 Antibiotic Med Clin Ther (New York) pmid:14435562
SALDANA TATE L In vivo and in vitro evaluation of oleandomycin, erythromycin, and tetracycline against cultures of Staphylococcus aureus. 1960 Antibiot Chemother (Northfield) pmid:14440930
SCHNEIERSON SS et al. Inhibition of Pseudomonas aeruginosa pigment formation by chloramphenicol and erythromycin. 1960 Antibiot Chemother (Northfield) pmid:14443279
HALL GA et al. Erythromycin stearate and propionyl erythromycin: a comparison of blood levels obtained after oral administration. 1960 Antibiotic Med Clin Ther (New York) pmid:14399035
HIRSCH HA et al. Effect of food on absorption of a new form of erythromycin propionate. 1960 Am. J. Med. Sci. pmid:14401969
ISENBERG HD et al. A clinical and laboratory evaluation of propionyl erythromycin. 1960 Antibiotic Med Clin Ther (New York) pmid:14405887